Skip to main content
. 2022 Dec 6;2022(12):CD013601. doi: 10.1002/14651858.CD013601.pub2

ISRCTN96315193.

Methods Parallel RCT (3‐arm)
Participants HD patients
Interventions
  1. rHuEPO

  2. L‐carnitine (IV)

  3. rHuEPO + L‐carnitine (IV)

Outcomes Hb
Notes Protocol registration only; current status is completed, the results is unknown